# US 2013/0158540 A1 · Method of treating tissue with radio frequency vascular electrode array > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2013/0158540 A1 - Document ID: US20130158540A1 - Status: Published application - Kind: A1 - Application number: 13/766,671 - Filed: 2013-02-13 - Published: 2013-06-20 - Earliest claimed: 2005-12-29 - Assignees: Boston Scientific Scimed, Inc. - Inventors: Arnold E. Oyola; Erin McKenna - Web page: https://patentgrep.com/patent/US20130158540A1 ## CPC - A61B 18/18: by applying electromagnetic radiation, e.g. microwaves - A61B 17/0057: {Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009)} - A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)} - A61B 2017/00641: {for closing fistulae, e.g. anorectal fistulae} - A61B 2017/22067: {Blocking; Occlusion (A61B2017/22054 takes precedence)} - A61B 2018/1472: {for use with liquid electrolyte, e.g. virtual electrodes} - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) ## Abstract A method of treating a patient is provided. The method comprises delivering an electrically conductive material within a vascular network, wherein the electrically conductive material embolizes in a region of the vascular network to form a vascular electrode array that assumes a geometry of the embolized region of the vascular network. The method may optionally comprise delivering a containment agent within the vascular network proximal to the delivered electrically conductive material to stabilize the vascular electrode array. The method further comprises applying electrical energy (e.g., radio frequency (RF) energy) to the vascular electrode array to therapeutically conduct electrical energy into a region of the targeted tissue adjacent the embolized region of the vascular network. ## Claims ### Claim 1 A method of treating targeted tissue adjacent a physiological vascular network contoured to the general shape and size of the targeted tissue, comprising: delivering a flowable self-embolizing material within the vascular network, wherein a portion of the material self-embolizes in a region of the vascular network to form a continuous multi-tined vascular array that assumes a geometry of the embolized region of the vascular network; and applying energy to the vascular array to thermally treat a region of the targeted tissue adjacent the embolized region of the vascular network. ### Claim 2 (depends on 1) The method of claim 1, wherein the embolized region of the vascular network comprises the entirety of the vascular network, and the adjacent region of the targeted tissue comprises the entirety of the targeted tissue. ### Claim 3 (depends on 1) The method of claim 1, wherein the vascular network carries blood. ### Claim 4 (depends on 1) The method of claim 1, wherein the vascular network supplies blood to the targeted tissue. ### Claim 5 (depends on 1) The method of claim 1, wherein the self-embolizing material is introduced into the vascular network and the energy is applied to the vascular array via a single probe. ### Claim 6 (depends on 1) The method of claim 1, wherein the energy is radio frequency (RF) energy. ### Claim 7 (depends on 1) The method of claim 1, wherein the adjacent region of the targeted tissue is ablated in response to the conduction of the energy. ### Claim 8 (depends on 1) The method of claim 1, wherein the vascular network comprises vessels that reduce in size at a periphery of the targeted tissue, and wherein the self-embolizing material comprises self-embolizing particles sized to lodge within a vessel at the periphery of the targeted tissue. ### Claim 9 (depends on 8) The method of claim 8, wherein the self-embolizing particles are doped with metallic sub-particles. ### Claim 10 (depends on 1) The method of claim 1, wherein the self-embolizing material has a viscosity that, when the energy is applied, prevents the vascular network from closing. ### Claim 11 (depends on 1) The method of claim 1, wherein the vascular array comprises a main shaft from which the tines of the continuous multi-tined array extend. ### Claim 12 (depends on 1) The method of claim 1, wherein the portion of the material that self-embolizes is biologically non-resorbable, so that the vascular array is permanent or semi-permanent, the method further comprising applying additional energy to the vascular array, whereby the additional energy thermally treats any anomalies in the corresponding region of targeted tissue region that have occurred after the previous application of energy. ### Claim 13 (depends on 1) The method of claim 1, further comprising delivering a containment agent within the vascular network proximal to the delivered self-embolizing material to stabilize the vascular array. ### Claim 14 (depends on 1) The method of claim 1, wherein the targeted tissue is a tumor. ### Claim 15 A method of treating a patient, comprising: delivering within a vascular network a material comprising self-embolizing flowable particles that embolize within the vascular network, wherein a portion of the material embolizes in the vascular network to form a continuous multi-tined vascular array that assumes a geometry of the vascular network; and applying energy to the vascular array to therapeutically conduct energy into the vascular network.